Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Tianjin Medical University Cancer Institute and Hospital)"
Count: 284
Selected: 0
NCT IDTitle
NCT03367884Neck Dissection vs Radiotherapy for Cervical Metastases in Advanced Hypopharyngeal Cancer
NCT03358602Radiotherapy vs Neck Dissection for Clinical T1/2N0 Supraglottic Cancer
NCT05273827Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium
NCT03708042A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer
NCT02765620PERCIST Criteria for Response Evaluation With Solid Tumors
NCT04807673Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)
NCT04079283Radiomics of Immunotherapeutics Response Evaluation and Prediction
NCT04900311Pyrotinib Versus Pertuzumab in Combination With Neoadjuvant Trastuzumab and Nab-Paclitaxel in HER2+ Early or Locally Advanced Breast Cancer
NCT04843215A Phase III Study Comparing Total and Partial Omentectomy for Patients With Advanced Gastric Cancer
NCT03992833Methods of Computed Tomography Screening and Management of Lung Cancer
NCT02272894A Trial to Evaluate the Superior Mesenteric Vein (14V) Lymphadenectomy for Distal Advanced Gastric Cancer
NCT03121846Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy
NCT03366883Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC
NCT02672488Metformin Plus Sorafenib for Advanced HCC
NCT02615223Endocrine Therapy With or Without Cryoablation for Stage IV Prostate Cancer
NCT02605226Cryoablation Therapy or Radiotherapy Therapy for Stage III Prostate Cancer
NCT03861221The Technical Operations And Standard Clinical Application Protocol of CBBCT in Diagnostic Process of Breast Cancer
NCT05356351An Open-label, Single-arm, Multicenter Phase II Clinical Study: Evaluating RC48-ADC Combined With Triplizumab in the Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cancer
NCT03837782Outcome of Resection for Colorectal Cancer
NCT05686434Osimertinib Therapy After Resection in High-risk Stage I EGFRm NSCLC (OSTAR)
NCT05685550Safety and Efficacy of Oral Etoposide Combined With Antirotinib and Envollizumab in Elderly Patients With Lung Cancer
NCT05683704Phase 2 Multi-center Randomized Study to the Efficacy and Safety of AK105 Combined With Anrotinib Hydrochloride in Patients With Recurrent/Refractory Classical Hodgkin's Lymphoma
NCT05679050Phase II Study on Sequential AG and FOLFIRINOX as Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer
NCT05678933AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH
NCT05672537Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence Risk
NCT05651672Pemigatinib in the Advanced Gastrointestinal Cancer With FGFR 1-3 Alterations
NCT05644392A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Treatment of Biliary Systemic Tumours
NCT05644379A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Advanced Hepatocellular Carcinoma
NCT05640791Durvalumab Combined With Chemotherapy Neoadjuvant Therapy of Biliary Tract Cancer
NCT05637268Carrelizumab Combined With Chemotherapy for Adjuvant Therapy of Esophageal Squamous Cell Carcinoma
NCT05627427Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard Chemotherapy
NCT05627414Conversion Therapy of Disitamab Vedotin Combined With Sintilimab and S-1 in HER2 Overexpression Gastric Cancer
NCT05621499HAIC or Lenvatinib Combined With Sintilimab for High Recurrence Risk Resectable Solitary Hepatocellular Carcinoma
NCT05620498Tislelizumab Combined With Lenvatinib and GEMOX Versus Tislelizumab Combined With GEMOX in Conversion Therapy of ICC and GBC.
NCT05616390Sintilimab Combined With Bevacizumab and Liver Protective Support Therapy in Unresectable Hepatocellular Carcinoma
NCT05596435Early Detection of Pancreatic Cancer
NCT05595590Radiotherapy With Tislelizumab in Patients With Recurrent Head & Neck Cancer
NCT05582109Envafolimab, Lenvatinib Combined With TACE in the Treatment of Unresectable Locally Advanced Hepatocellular Carcinoma
NCT05560334A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
NCT05560308Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI Therapy
NCT05535647Second Line Therapy for Advanced Intrahepatic Cholangiocarcinoma
NCT05524155Sintilimab Combined With Regorafenib and HAIC in Patients With Colorectal Liver Metastasis
NCT05522985Neoadjuvant Chemotherapytreatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT05519410Sintilimab Combined With Lenvatinib Versus HAIC for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma
NCT05507606Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations
NCT05507593Study of DLL3-CAR-NK Cells in the Treatment of Extensive Stage Small Cell Lung Cancer
NCT05490719A Phase II Study of CRT Combined With QL1706 in ESCC Patients
NCT05476380Neoadjuvant Therapy of Camrelizumab Combined With Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
NCT05458180CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma
NCT05449483Conversion of Tislelizumab Combined With Chemotherapy in Unresectable Esophageal Squamous Cell Carcinoma